TNF Pharmaceuticals (TNFA)

Profile

Full Name

TNF Pharmaceuticals, Inc.

Ticker Symbol

TNFA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://tnfpharma.com

Employees

6

Key Details

Price

$0.27(0.00%)

Market cap

$743.88K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$5.33(+54.60% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.27
TNFA price is $0.27

30-Day Relative Volume

0.17
TNFA 30-day relative volume is 0.17

Price Performance

Price Today change

0%
TNFA {parameterFullLabel} is unchanged today

Price YTD change

-76.52%
TNFA price is down -76.52% since January 1st

Price 1-year change

-88.11%
TNFA price is down -88.11% year-on-year

Price 3-year change

-99.77%
TNFA price is down -99.77% over the past 3 years

Price Range

Price All-time high

$65664.00
TNFA price is currently -100.00% below its historical high of $65664.00

Price 3-year low

$0.21
TNFA price is currently +27.96% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$743.88K
TNFA market capitalization is $743.88 thousand

Market cap 3-year change

-99.5%
TNFA market capitalization is down -99.5% over the past 3 years

Market cap All-time high

$362.59M
TNFA market capitalization is currently -99.79% below its historical high of $362.59 million

Market cap sector rank

3.54%
TNFA market capitalization is higher than 3.54% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+27.69%
TNFA shares outstanding is up +27.69% year-on-year

Shares Outstanding 3-Year Change

+117.18%
TNFA shares outstanding is up +117.18% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.04
TNFA beta is 0.04

200-day SMA

$1.23
TNFA price is currently -78.12% below its 200-day simple moving average

50-day SMA

$0.42
TNFA price is currently -35.02% below its 50-day simple moving average

RSI

32.71
TNFA 14-day relative strength index is 32.71

Volume

0.17
TNFA 30-day relative volume is 0.17

ATR

$0.05
TNFA average true range is $0.05

10-day Historical Volatility

150.91%
TNFA 10-day historical volatility is 150.91%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
TNFA annual revenue value is unknown

Revenue Analysts estimate

-
TNFA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
TNFA annual revenue 1-year change is unknown

Revenue Sector rank

-
TNFA annual revenue is unknown

EPS

EPS

-$5.33
TNFA annual earnings per share is -$5.33

EPS Analysts estimate

-
TNFA annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+54.6%
TNFA annual earnings per share is up +54.6% year-on-year

EPS Sector rank

18.36%
TNFA annual earnings per share is higher than 18.36% of companies in Healthcare sector

Profit

Gross profit

$0.00
TNFA annual gross profit is $0.00

Gross margin

-
TNFA annual gross profit margin value is unknown

Operating profit

-$16.36M
TNFA annual operating income is -$16.36 million

Operating margin

-
TNFA annual operating profit margin value is unknown

Net income

-$4.00M
TNFA annual net profit is -$4.00 million

Net margin

-
TNFA annual net profit margin value is unknown

Expenses

Total expenses

$16.36M
TNFA annual total expenses is $16.36 million

Operating expenses

$16.36M
TNFA annual total operating expenses is $16.36 million

Cost of goods sold

-
TNFA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$8.49M
TNFA annual SGA is $8.49 million

Depreciation and amortization

-
TNFA annual depreciation & amortization value is unknown

Interest expense

-
TNFA annual interest expense value is unknown

Income tax

$0.00
TNFA annual income tax is $0.00

EBIT & EBITDA

EBIT

-$16.36M
TNFA annual earnings before interest & taxes is -$16.36 million

EBITDA

-$16.36M
TNFA annual EBITDA is -$16.36 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$17.86M
TNFA annual total assets is $17.86 million

Non current assets

$12.05M
TNFA annual long term assets is $12.05 million

Current assets

$5.82M
TNFA annual total current assets is $5.82 million

Cash and cash equivalents

$2.68M
TNFA annual cash & cash equivalents is $2.68 million

Accounts receivable

-
TNFA annual accounts receivable value is unknown

Inventory

-
TNFA annual inventory value is unknown

Liabilities

Total liabilities

$5.09M
TNFA annual total liabilities is $5.09 million

Long term liabilities

$504.60K
TNFA annual total long term liabilities is $504.60 thousand

Current liabilities

$4.99M
TNFA annual total current liabilities is $4.99 million

Accounts payable

$3.08M
TNFA annual accounts payable is $3.08 million

Debt

Total debt

$48.90K
TNFA annual total debt is $48.90 thousand

Total debt 1-year change

-65.49%
TNFA annual total debt is down -65.49% year-on-year

Long term debt

$0.00
TNFA annual long term debt is $0.00

Short term debt

$48.90K
TNFA annual short term debt is $48.90 thousand

Equity & Capital

Shareholders equity

$12.77M
TNFA annual stockholders equity is $12.77 million

Book value

$12.22M
TNFA annual book value is $12.22 million

Retained earnings

-$101.98M
TNFA annual retained earnings is -$101.98 million

Working capital

$828.20K
TNFA annual working capital is $828.20 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$12.98M
TNFA annual cash flow from operations is -$12.98 million

Cash from operations 1-year change

-5.79%
TNFA annual cash flow from operations is down -5.79% year-on-year

Cash from investing

$1.85M
TNFA annual cash flow from investing activities is $1.85 million

Cash from investing 1-year change

-73.3%
TNFA annual cash flow from investing activities is down -73.3% year-on-year

Cash from financing

$13.07M
TNFA annual cash flow from financing activities is $13.07 million

Cash from financing 1-year change

+135.44%
TNFA annual cash flow from financing activities is up +135.44% year-on-year

CAPEX

CAPEX

-
TNFA annual capital expenditures value is unknown

CAPEX 1-year change

-
TNFA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$12.98M
TNFA annual free cash flow is -$12.98 million

Free cash flow 1-year change

-5.79%
TNFA annual free cash flow is down -5.79% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
TNFA annual gross profit margin value is unknown

Operating margin

-
TNFA annual operating profit margin value is unknown

Net margin

-
TNFA annual net profit margin value is unknown

ROA & ROE

ROA

-22.39%
TNFA annual return on assets is -22.39%

ROE

-31.31%
TNFA annual return on equity is -31.31%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TNFA price to earnings ratio value is unknown

PE ratio Sector rank

-
TNFA price to earnings ratio is unknown

PB Ratio

PB ratio

0.04
TNFA price to book ratio is 0.04

PB ratio Sector rank

17.12%
TNFA price to book ratio is higher than 17.12% of companies in Healthcare sector

PS Ratio

PS ratio

-
TNFA price to sales ratio value is unknown

PS ratio Sector rank

-
TNFA price to sales ratio is unknown

Enterprise value

Enterprise value

-$430.22K
TNFA enterprise value is -$430.22 thousand

Enterprise value Sector rank

11.24%
TNFA enterprise value is higher than 11.24% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.04
TNFA EV/EBITDA is 0.04

EV/EBITDA Sector rank

65.57%
TNFA EV/EBITDA is higher than 65.57% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.17
TNFA annual current ratio is 1.17

Quick ratio

-
TNFA annual quick ratio value is unknown

Leverage

Debt to equity

0.00
TNFA annual debt to equity ratio is 0.00

Interest coverage ratio

-
TNFA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
TNFA piotroski f-score value is unknown

Altman Z-Score

-
TNFA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

STSS logo
Sharps Technology (STSS)
LGMK logo
LogicMark (LGMK)
NIVF logo
NewGenIvf Group Limited (NIVF)
VIRX logo
Viracta Therapeutics (VIRX)
SCPX logo
Scorpius Holdings (SCPX)
ATXI logo
Avenue Therapeutics (ATXI)
SYRS logo
Syros Pharmaceuticals (SYRS)
NEPT logo
Neptune Wellness Solutions (NEPT)
ONCO logo
Onconetix (ONCO)
  • What is the ticker symbol for TNF Pharmaceuticals?
  • Does TNF Pharmaceuticals pay dividends?
  • What sector is TNF Pharmaceuticals in?
  • What industry is TNF Pharmaceuticals in?
  • What country is TNF Pharmaceuticals based in?
  • Is TNF Pharmaceuticals in the S&P 500?
  • Is TNF Pharmaceuticals in the NASDAQ 100?
  • Is TNF Pharmaceuticals in the Dow Jones?
  • When was TNF Pharmaceuticals's last earnings report?
  • When does TNF Pharmaceuticals report earnings?

What is the ticker symbol for TNF Pharmaceuticals?

The ticker symbol for TNF Pharmaceuticals is NASDAQ:TNFA

Does TNF Pharmaceuticals pay dividends?

No, TNF Pharmaceuticals does not pay dividends

What sector is TNF Pharmaceuticals in?

TNF Pharmaceuticals is in the Healthcare sector

What industry is TNF Pharmaceuticals in?

TNF Pharmaceuticals is in the Biotechnology industry

What country is TNF Pharmaceuticals based in?

TNF Pharmaceuticals is headquartered in United States

Is TNF Pharmaceuticals in the S&P 500?

No, TNF Pharmaceuticals is not included in the S&P 500 index

Is TNF Pharmaceuticals in the NASDAQ 100?

No, TNF Pharmaceuticals is not included in the NASDAQ 100 index

Is TNF Pharmaceuticals in the Dow Jones?

No, TNF Pharmaceuticals is not included in the Dow Jones index

When was TNF Pharmaceuticals's last earnings report?

TNF Pharmaceuticals's most recent earnings report was on Nov 14, 2024

When does TNF Pharmaceuticals report earnings?

The next expected earnings date for TNF Pharmaceuticals is May 15, 2025
On this page